H. Tsushima et al., Fas antigen (CD95) in pure erythroid cell line AS-E2 is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates apoptotic death, EXP HEMATOL, 27(3), 1999, pp. 433-440
We investigated the expression of Fas antigen (CD95) in the pure erythroid
cell line AS-E2 in the presence and absence of interferon-gamma (IFN-gamma)
and tumor necrosis factor-alpha (TNF-alpha), TNF-alpha induced apoptosis i
n AS-E2 cells, whereas IFN-gamma did not. In culture containing no IFN-gamm
a, or TNF-alpha, AS-E2 cells expressed Little Fas antigen. However, IFN-gam
ma and TNF-alpha both induced expression of Fas antigen and its mRNA within
24 hours after the stimulation. When anti-Fas monoclonal antibody (IgM) wa
s added to AS-E2 cells after the induction of Pas expression, AS-E2 cells u
nderwent apoptosis as shown by the induction of DNA fragmentation, This apo
ptotic change was inhibited by an inhibitor of caspase-3-like proteases (Ac
-DEVD-CHO) and an inhibitor of CED3/ICE family proteases (Z-Asp-CH2-DCB) bu
t not by an inhibitor of caspase-1-like proteases (Ac-YVAD-CHO), suggesting
a role for caspase-3-like proteases in Pas-receptor signaling. Although AS
-E2 cells expressed Fas ligand mRNA, treatment with ZB4, an antibody that i
nhibits Fas-mediated cell death, failed to suppress IFN-gamma- or TNF-alpha
-mediated cytotoxicity. These findings suggest that the late erythroid prog
enitor cells are negatively regulated by IFN-gamma and TNF-alpha, both of w
hich are capable of inducing functional Fas expression, (C) 1999 Internatio
nal Society for Experimental Hematology, Published by Elsevier Science Inc.